{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:54:44Z","timestamp":1790902484849,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ero.2026.03.021","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:36:31Z","timestamp":1776944191000},"page":"100173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In search of a window of opportunity in axial spondyloarthritis: treatment outcomes across different symptom durations"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5896-2230","authenticated-orcid":false,"given":"Annik","family":"Steimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"G\u00f6tschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ramiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"B\u00fcrki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Andor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Grosswiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Kyburz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Br\u00fclhart Bletsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"F\u00f6rger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Micheroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Ciurea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2026.03.021_bib0001","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","article-title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomized placebo-controlled trial (ABILITY-1)","volume":"72","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.03.021_bib0002","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/keac532","article-title":"Treating spondyloarthritis early: does it matter? Results from a systematic literature review","volume":"62","author":"Capelusnik","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.03.021_bib0003","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard-2023-224232","article-title":"ASAS consensus definition of early axial spondyloarthritis","volume":"83","author":"Navarro-Comp\u00e1n","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.03.021_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003455","article-title":"Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry","volume":"9","author":"Ciurea","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.ero.2026.03.021_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-005110","article-title":"Efficacy of upadacitinib in subgroups of patients with axial spondyloarthritis with early versus established disease","volume":"11","author":"Navarro-Comp\u00e1n","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.ero.2026.03.021_bib0006","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13075-026-03729-6","article-title":"Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years","volume":"28","author":"Ramiro","year":"2026","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2026.03.021_bib0007","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1093\/rheumatology\/keaf382","article-title":"Does symptom duration impact on treatment response in axial spondyloarthritis? A meta-analysis of randomized controlled trials","volume":"64","author":"Benavent","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ero.2026.03.021_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-006647","article-title":"Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of \u22641 year of back pain: longitudinal observational data from the SCQM registry","volume":"12","author":"Bachmann","year":"2026","journal-title":"RMD Open"},{"key":"10.1016\/j.ero.2026.03.021_bib0009","first-page":"1","article-title":"mice: Multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.ero.2026.03.021_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12874-025-02515-3","article-title":"Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased","volume":"25","author":"Polysopoulos","year":"2025","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ero.2026.03.021_bib0011","series-title":"Multiple imputation for nonresponse in surveys","author":"Rubin","year":"1987"},{"issue":"9","key":"10.1016\/j.ero.2026.03.021_bib0012","doi-asserted-by":"crossref","first-page":"e652","DOI":"10.1016\/S2665-9913(25)00108-0","article-title":"The imaging crisis in axial spondyloarthritis","volume":"7","author":"Diekhoff","year":"2025","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"10.1016\/j.ero.2026.03.021_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ero.2026.03.021_bib0014","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ard.2025.10.016","article-title":"Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of life","volume":"85","author":"Ortolan","year":"2026","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ero.2026.03.021_bib0015","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/ard.2011.150037","article-title":"A stratified model for health outcomes in ankylosing spondylitis","volume":"70","author":"Machado","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.03.021_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105603","article-title":"Looking through the window of opportunity in axial spondyloarthritis?","volume":"90","author":"Benavent","year":"2023","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ero.2026.03.021_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000870","article-title":"Window of opportunity in rheumatoid arthritis \u2013 definitions and supporting evidence: from old to new perspectives","volume":"5","author":"Burgers","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.ero.2026.03.021_bib0018","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.berh.2014.10.008","article-title":"Bone formation in axial spondyloarthritis","volume":"28","author":"Lories","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.ero.2026.03.021_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11926-017-0681-5","article-title":"Mechanism of new bone formation in axial spondyloarthritis","volume":"19","author":"Poddubnyy","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ero.2026.03.021_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","article-title":"TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort","volume":"77","author":"Molnar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.03.021_bib0021","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/art.40661","article-title":"Impact of tumor necrosis cactor inhibitor versus nonsteroidal antiinflammatory drug treatment on radiographic progression in early ankylosing spondylitis: its relationship to inflammation control during treatment","volume":"71","author":"Park","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ero.2026.03.021_bib0022","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2019-216741","article-title":"Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence","volume":"79","author":"Koo","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.03.021_bib0023","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.41667","article-title":"Tumor necrosis factor inhibitors reduce spinal radiographic progression in patients with radiographic axial spondyloarthritis: a longitudinal analysis from the Alberta prospective cohort","volume":"73","author":"Sepriano","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ero.2026.03.021_bib0024","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/annrheumdis-2022-222324","article-title":"Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis","volume":"81","author":"Torgutalp","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2026.03.021_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2025.105952","article-title":"Evaluating the impact of the ASAS early axial spondyloarthritis definition on radiographic progression over 12 years","volume":"93","author":"Nam","year":"2026","journal-title":"Joint Bone Spine"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:17:29Z","timestamp":1790900249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708126000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3050708126000728"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2026.03.021","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In search of a window of opportunity in axial spondyloarthritis: treatment outcomes across different symptom durations","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2026.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100173"}}